Bringing the fundamentals into focus…
Back to BridgeBio Pharma, Inc.
How BridgeBio Pharma, Inc. stacks up
BBIO · against 1,335 other Healthcare companies
Profitability
10/ 100
Near the bottom of its peers.
Ranked #1,196 of 1,336 · scores higher than 10% of peers
Bars: peers in each 10-point band of the profitability score134 peers with a profitability score of 10–19, including BBIO · Click a bar to see the companies
Why profitability scores 10?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 96% of peers. Return on invested capital: -183.3% vs peer median 4.7%
- a lower return on assets: weaker than 95% of peers. Return on assets: -57.7% vs peer median 1.7%
- a thinner operating margin: weaker than 85% of peers. Operating margin: -69.8% vs peer median 7.1%
Metric by metric
Position: dot = BBIO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BBIO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | -183.3% | 4.7% | 4% | 33% | |
| Operating marginHigher is better · 1,251 reported | -69.8% | 7.1% | 15% | 33% | |
| Return on assetsHigher is better · 1,315 reported | -57.7% | 1.7% | 5% | 33% | |
| Return on equityHigher is better · 1,252 reported | Not reported | 3.2% | — | — | Context only |
| Gross marginHigher is better · 1,394 reported | 94.4% | 45.9% | 96% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around BBIO| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 1,196 | 7.2B TWD (≈$224M) | 10 | 41 | |
| 1,196 | 3.9B USD | 10 | 47 | |
| 1,196 | 377M USD | 10 | 29 | |
| 1,196 | 334M USD | 10 | 36 | |
| 1,196 | 14.5B USD | 10 | 30 | |
| 1,196 | 250M SEK (≈$25M) | 10 | 44 | |
| 1,196 | 126M USD | 10 | 32 | |
| 1,196 | 6.2B USD | 10 | 44 | |
| 1,196 | 8.8B USD | 10 | 31 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score